EcoDrugPlus

Cholinergic Receptor, Muscarinic 5a

Ensembl ID : ENSFHEG00000014235
Gene Symbol: CHRM5A
1 Cross references
195 Possible Orthologues:

Coagulation Factor Vii-Like

Ensembl ID : ENSFHEG00000023015
Gene Symbol: LOC105923737
3 Cross references
203 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSFHEG00000008395
Gene Symbol: LOC105922736
3 Cross references
244 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSFHEG00000003821
Gene Symbol: LOC105916753
2 Cross references
202 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSFHEG00000022344
Gene Symbol: CCDC6
3 Cross references
208 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSFHEG00000013702
Gene Symbol: LOC105928083
2 Cross references
247 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSFHEG00000014282
Gene Symbol: CSF1R
3 Cross references
207 Possible Orthologues:

Complement C1r Subcomponent

Ensembl ID : ENSFHEG00000012901
Gene Symbol: LOC105931568
2 Cross references
177 Possible Orthologues:

Corticotropin-Releasing Factor Receptor 1-Like

Ensembl ID : ENSFHEG00000010071
Gene Symbol: LOC105926480
2 Cross references
208 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSFHEG00000018019
Gene Symbol: CCND1
3 Cross references
232 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSFHEG00000013183
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSFHEG00000007869
Gene Symbol: CDK2
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).